News › Pharmaceuticals  ·  13 Mar 2026, 7:00 AM IST  ·  4 months ago

Mixed Cues: Lupin, NTPC Recommended Amidst Nifty Decline

Bias: Bullish +3075% confidencePharmaceuticalsPowerMixed read

In one line — Consider selective long positions in Lupin and NTPC, as recommended by Religare Broking, while maintaining caution on the broader Nifty 50 trend.

Bearish
Bullish
−1000+30+100

Source: Mint · AI-summarised by Anadi · Updated 13 Mar 2026, 9:00 AM IST

Pharmaceuticalswatching
Powerwatching

What Happened

Ajit Mishra from Religare Broking has provided specific buy recommendations for Lupin and NTPC, even as the broader Nifty 50 index is experiencing declines. This suggests a strategy of identifying resilient or undervalued stocks during a market downturn.

Why It Matters (for you)

This matters for traders as it highlights that not all stocks follow the broader market trend. Analyst recommendations can guide investors to potential outperformers or defensive plays, offering opportunities to generate alpha even in challenging market conditions.

Impact on Indian Markets

Lupin (LUPIN) and NTPC (NTPC) are likely to see positive sentiment and potential buying interest following these recommendations. The pharmaceutical sector often acts as a defensive play, while power stocks like NTPC can offer stability and dividend yield, attracting investors during volatility.

What Traders Should Watch Next

Traders should monitor the price action of Lupin and NTPC for confirmation of buying interest and observe the Nifty 50's overall trend for signs of reversal or further decline. Look for volume accompanying any price movements in the recommended stocks.

Key Evidence

  • Ajit Mishra of Religare Broking provides insights for navigating the current tumultuous market.
  • Nifty 50 is experiencing declines.
  • Mishra highlights opportunities in stocks like Lupin and NTPC.